Drug intelligence / Profile preview

hydrocortisone + fludrocortisone

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Hydrocortisone + fludrocortisone is a combination therapy used primarily for the treatment of adrenal insufficiency, such as Addison's disease and congenital adrenal hyperplasia. Hydrocortisone is a synthetic glucocorticoid that mimics cortisol, providing anti-inflammatory and immunosuppressive effects. Fludrocortisone is a synthetic mineralocorticoid structurally related to cortisol but with strong aldosterone-like activity, helping to regulate sodium retention and potassium excretion. The combination replaces both glucocorticoid and mineralocorticoid activity in patients whose adrenal glands do not produce sufficient endogenous corticosteroids. This dual replacement improves prognosis in conditions like catecholamine-resistant septic shock with relative adrenal insufficiency by supporting vascular responsiveness and fluid balance[5][6][8].

Brand names
AstoninAstonin-HCortineffFlorinefeFludrocortison
Other names
hydrocortisone + fludrocortisone acetate
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on hydrocortisone + fludrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + fludrocortisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call